Artificial Intelligence is the proverbial Wild West, at least that's what concerns many skeptics. Please join ITIF's Center for Data Innovation in partnership with NIST for a conversation about the state of play in developing standards and oversight of AI systems, the need for proper governance of AI in key industries like health care and transportation, and the role that policymakers can play in advancing these efforts.
There has been a global consensus for nearly a century that countries should tax multinational companies in the jurisdictions where they create value, not where they generate sales.
Please join ITIF for an expert panel discussion on the current state and future potential of robotics across all sectors of the U.S. economy. Where are we today with robotic development? What are the key technological challenges to overcome? What is the government’s role in supporting robotics development and adoption? And, of course, what is the likely impact on employment?
Sustained innovation in clean industrial processes is necessary to avert the worst consequences of climate change, better serve the diverse demands of the American public and enhance U.S. economic competitiveness and national security. The federal government plays a key role in fostering innovation and encouraging cleantech entrepreneurship and investment.
While the Internet has enabled many types of transactions to become digital, many of these records are still maintained by a centralized authority, such as a bank or government agency.
Join ITIF for the release of a new report—“A Policymaker’s Guide to Road User Charges”—and an expert panel discussion that will delve into the myths and realities of having a “road user charge” system (RUC) that uses technology to log the mileage of cars and trucks and charge them accordingly.
Sustained innovation in energy technologies is necessary to avert the worst consequences of climate change, better serve the diverse demands of the American public and enhance U.S. economic competitiveness and national security.
America’s ability to compete globally in biomedical innovation is being threatened. China, India, Russia, and other competitors have meaningfully increased their government support for biomedical research, which has allowed them to challenge U.S.